HilleVax

📍 Boston, United States🗓 Founded 2021👥 63 employees💰 Last funded Sep 2021
Biotechnology Research🌐 hillevax.com
Website LinkedIn
HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Our initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in HilleVax?
HilleVax has 1 investors on record on gritt.io, including 1 early-stage backers.
When did HilleVax last raise funding?
The most recent investment in HilleVax recorded on gritt.io was in September 2021.
When was HilleVax founded?
HilleVax was founded in 2021.
What industry is HilleVax in?
HilleVax operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is HilleVax based?
HilleVax is headquartered in Boston, United States.